Question Bank › The company is outgrowing its own explanations

The company is outgrowing its own explanations

The company is outgrowing its own explanations: management keeps telling investors the reported numbers are not the busi

Calls Tested
497
Answered YES
13
Hit Rate
2.6%
rare by design

Intra-Cellular Therapies, Inc. (ITCI) — this company's answers

NO on the Q4 2017 call 2018-03-01 D
The model's full reasoning — Q4 2017 call → NO我们根据指令,需要判断管理层是否在电话会议中传达:报告期(2017年Q4和全年)的结果不代表公司目前实际运营的业务,即管理层反复或实质性地表明,刚报告的数字描述的公司已经被现在公司内部实际发生的事情所超越。 分析电话会议内容: - 管理层提到2017年取得的进展,包括lumateperone的NDA准备、bipolar depression的Phase 3试验、ITI-214的Phase 1/2试验等。 - 他们提到2018年计划,包括提交NDA、启动新研究等。 - 关于财务,他们给出了2017年Q4和全年的净亏损,以及现金状况。 - 他们提到2018年预计支出180-200百万美元,用于推进各项开发。 关键点:管理层是否明确表示报告期数字已经过时,当前业务已经超越报告期?他们提到“we are preparing for a launch for lumateperone”,但这是未来计划。他们提到“we ended of the year with $464.3 million in cash”,这是报告期数字。他们提到“we expect to spend between $180 million and $200 million”在2018年,这是未来。 管理层没有明确说报告期数字不代表当前业务。他们讨论的是进展和未来计划,但报告期是2017年,而当前是2018年,所以任何公司都会说当前业务比报告期更先进,但这是常规的。指令要求的是“repeatedly or substantially indicate that the just-reported numbers describe a company that has already been left behind by what is now actually happening inside the business”。管理层没有强调这种差距,而是常规地回顾过去和展望未来。 例如,他们提到“we made important progress in the development of our lead product candidate”,这是常规。他们提到“we intend to submit our NDA for lumateperone for the treatment of schizophrenia by mid-2018”,这是未来计划。他们没有说报告期的数字没有反映当前正在进行的活动,比如他们提到“Clinical conduct in our long-term open label safety study is ongoing”,但这是常规。 管理层没有说“报告期数字已经过时”或类似的话。他们只是正常地报告结果和展望。 因此,答案应为NO。

← Back to the full ITCI analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management convey that the company's REPORTED RESULTS FOR THE PERIOD BEING DISCUSSED DO NOT REPRESENT THE BUSINESS THE COMPANY IS ACTUALLY RUNNING TODAY — that is, does management repeatedly or substantially indicate that the just-reported numbers describe a company that has already been left behind by what is now actually happening inside the business? Answer YES when management's own words convey, in whatever form fits the business, ONE coherent posture: the printed period is stale relative to the operating present. Any genuine expression of this counts, and the form varies widely across industries. For example — management explaining that meaningful business, capability, or activity now in motion contributed little or nothing to the reported period because it began late in the period or just after it closed; management noting that the pace, level, or mix of business the company is currently running sits above what the period's figures show; management describing that the period carried the costs of things whose benefits have only just begun; management pointing to what the company has already become — what it can now do, what it now has, what is now committed or underway — and treating the reported numbers as a picture of the company before that; or management consistently answering questions about the future by pointing to what is already in hand, in motion, or being executed rather than to what must still be won. What matters is the DIRECTION OF THE GAP in management's own telling: the business as it stands today is ahead of the business as it appears in the reported period, and management itself is the one drawing attention to that gap, grounded in things that are already real — actual current activity, completed work, committed business, or capabilities already in place — not in hopes, plans, market size, or projections. Answer NO if the call is a conventional results-and-outlook discussion in which the reported period and the described business are essentially the same size — ordinary strength, ordinary guidance, however good. NO if the claimed gap rests mainly on pipeline, bids, negotiations, market opportunity, hoped-for demand, or initiatives with nothing concrete yet occurring. NO if the only "numbers lag the business" language is a single passing remark or boilerplate about investing for the future, with no substance about what has already changed. NO if management is chiefly defending weak results, explaining a slump, or promising a future turnaround from a trough. NO if the recent developments are routine in scale for this company — the normal cadence of wins, openings, or orders it always reports — with no sense that the business has moved to a different level than the print. NO if the gap is asserted only in an analyst's question or model that management does not itself affirm with its own account of current operations. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
KOPN Kopin Corporation Q4 2023 2024-03-14 C+
PFE Pfizer Inc. Q4 2023 2024-01-30 F
SCPH scPharmaceuticals Inc. Q3 2023 2023-11-08 B
NBTX Nanobiotix S.A. Q2 2023 2023-09-27 D
PRPH ProPhase Labs, Inc. Q1 2023 2023-05-11 F
VRE Veris Residential, Inc. Q4 2022 2023-02-22 D
SOL ReneSola Ltd Q3 2022 2022-12-01 C+
FLL Full House Resorts, Inc. Q3 2022 2022-11-07 B
OPK OPKO Health, Inc. Q1 2022 2022-05-09 D
FAT FAT Brands Inc. Q4 2021 2022-03-21 F
OWL Blue Owl Capital Inc. Q2 2021 2021-08-10 B+
PRIM Primoris Services Corporation Q2 2018 2018-08-11 C+
LIND Lindblad Expeditions Holdings, Inc. Q2 2017 2017-08-06 C

How the model reasoned

VRE · Q4 2022 → YESThe question is: Does management convey that the reported results for the period do not represent the business the company is actually running today? That the just-reported numbers describe a company ...YES The transcript shows management repeatedly framing the reported period as transitional and not reflective of the current business: the shift to a pure-play multi-family company has already reduced office and hotel exposure while driving multi-family NOI share to 98%, with Haus25 leased at 95% ahead of schedule and same-store NOI guidance of 4-6% for 2023. They explicitly note that earnings variability stems from the ongoing asset sales and reallocation, with the business now positioned for growth as the transformation concludes, and they highlight post-period activity like additional sales and stabilized properties to underscore that the reported numbers capture a pre-transition state.
PFE · Q4 2023 → YESThe question is: Does management convey that the reported results do not represent the business the company is actually running today? That the just-reported numbers describe a company that has alread...NO The transcript shows management framing 2023 results as a challenging year with declines driven by COVID products, while positioning 2024 as a year of execution and growth through new priorities like the Seagen acquisition (closed late in 2023 with minimal contribution) and new product launches. This is a standard results-and 2024 outlook discussion, with forward-looking elements on pipeline, margins, and capital allocation rather than indicating the reported period is stale relative to current operations.
PRIM · Q2 2018 → YESThe question is whether management conveys that the reported results for Q2 2018 do not represent the business the company is actually running today. Specifically, if the printed period is stale relat...YES The transcript shows management repeatedly framing the Q2 results as a partial picture due to the late June 1 acquisition of Willbros. They note the business is "running as planned," highlight one-month revenue contribution of $1.

More from the question bank

Undersized for what it has already been handMid-period crossingsSelf-authored recoveryTheir own money on the lineGrowing out of the old selfGrowing out of the old selfAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.